Relief Therapeutics Holding (Relief Therapeutics Holding) Median PS Value : $0.00 (As of Apr. 30, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Relief Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.586. Relief Therapeutics Holding's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-04-30), Relief Therapeutics Holding's share price is $1.325. Relief Therapeutics Holding's Median PS Value is $0.00. Therefore, Relief Therapeutics Holding's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Relief Therapeutics Holding's Median PS Value or its related term are showing as below:

RLFTF's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.64
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Relief Therapeutics Holding Median PS Value Historical Data

The historical data trend for Relief Therapeutics Holding's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Median PS Value Chart

Relief Therapeutics Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Median PS Value

Get a 7-Day Free Trial

Relief Therapeutics Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Median PS Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Relief Therapeutics Holding's Median PS Value

For the Biotechnology subindustry, Relief Therapeutics Holding's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Relief Therapeutics Holding's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Price-to-Median-PS-Value falls into.

Relief Therapeutics Holding Median PS Value Calculation

Relief Therapeutics Holding's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.586	*	0
	=	0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Relief Therapeutics Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.586.

Relief Therapeutics Holding (OTCPK:RLFTF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Relief Therapeutics Holding's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	1.325	/	0.00
	=

Relief Therapeutics Holding Median PS Value Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (Relief Therapeutics Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFz:UK RLF:Switzerland

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.